Epilepsy, antiepileptic drugs (AEDs) and cognition

Acta Neurologica Scandinavica, Supplement

Volumn 108, Issue 180, 2003, Pages 23-32

  Hirsch, E ^a   Schmitz, B ^b   Carreno M ^c  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b HUMBOLDT UNIVERSITY   (Germany)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Children; Cognitive deficits; Elderly; Psychiatric disorders; Valproate

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; LITHIUM; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; SERUM ALBUMIN; STEROID; TIAGABINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; BENZODIAZEPINE; METHYLPHENIDATE; SULTIAME;

AGE; BRAIN DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEPRESSION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMAN; INTELLIGENCE QUOTIENT; LANDAU KLEFFNER SYNDROME; LOBECTOMY; PSYCHOSIS; SOCIAL PSYCHOLOGY; WEST SYNDROME; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHORIA; ELECTROENCEPHALOGRAM; FOCAL EPILEPSY; HYPOMANIA; INSOMNIA; IRRITABILITY; MANIA; MORBIDITY; PRESCRIPTION; PREVALENCE; RISK FACTOR; SCHIZOPHRENIFORM DISORDER; SEIZURE; SIDE EFFECT; WITHDRAWAL SYNDROME; ADOLESCENT; ADULT; AGED; CHILD; DECISION MAKING; INFANT; MENTAL DISEASE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; REVIEW;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DECISION MAKING; DEPRESSION; EPILEPSY; HUMANS; INFANT; INFANT, NEWBORN; LANDAU-KLEFFNER SYNDROME; MENTAL DISORDERS; MIDDLE AGED; RISK FACTORS;

EID: 0242267015     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. ENGEL J JR. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42:796-803.
2. BULTEAU C, JAMBAQUE I, VIGUIER D, KIEFFER V, DELLATOLAS G, DULAC O. Epileptic syndromes, cognitive assessment and school placement. a study of 251 children. Dev Med Child Neurol 2000;42:319-27.
3. DULAC O. What is West syndrome? Brain Dev 2001;23:447-52.
4. DULAC O. Epileptic encephalopathy. Epilepsia 2001;42 (Suppl. 3):23-6.
5. PLOUIN P, RAFFO E, DE OLIVEIRA T. Prognosis of neonatal seizures. In: JALLON P, ed. Prognosis of epilepsies. Paris: John Libbey Eurotext, 2003: 199-209.
6. PEDESPAN JM, LOISEAU H, VITAL A, MARCHAL C, FONTAN D, ROUGIER A. Surgical treatment of an early epileptic encephalopathy with suppression-bursts and focal cortical dysplasia. Epilepsia 1995;36:37-40.
7. GRANSTRM M-L. Prognosis of infantile spasms. In: JALLON P, ed. Prognosis of epilepsies. Paris: John Libbey Eurotext, 2003: 210-20.
8. CLAES L, CEULEMANS B, AUDENART D et al. De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat 2003;21:615-21.
9. SCHEFFER IE, WALLACE R, MULLEY JC, BERKOVIC SF. Clinical and molecular genetics of myoclonic-astatic epilepsy and severe myoclonic epilepsy in infants (Dravet syndrome). Brain Rev 2002;23:732-35.
10. BASSELET C, MOTTE J. Prognosis of idiopathic localisation-related epilepsies. In: JALLON P, ed. Prognosis of epilepsies. Paris: John Libbey Eurotext, 2003: 265-76.
11. METZ-LUTZ MN, MAQUET P, DE SAINT MARTIN A et al. Pathophysiological aspects of Landau-Kleffner syndrome: from the active epilepsy phase to recovery. Int Rev Neurobiol 2001;45:505-26.
12. SAINT-MARTIN AD, CARCANGIU R, ARZIMANOGLU A et al. Semiology of typical and atypical Rolandic epilepsy: a video-EEG analysis. Epileptic Disord 2001;3:173-82.
13. SCHMITZ EB, ROBERTSON MM, TRIMBLE MR. Depression and schizophrenia in epilepsy: social and biological risk factors. Epilepsy Res 1999;35:59-68.
14. KANNER AM, KOZAK AM, FREY M. The use of sertraline in patients with epilepsy: is it safe? Epilepsy Behav 2000;1:100-5.
15. MATSUURA M. Epileptic psychoses and anticonvulsant drug treatment. J Neurol Neurosurg Psychiatry 1999;67:231-3.
16. SCHMIDT D. Epilepsien und Epileptische Anfälle. Stuttgart: Thieme, 1992.
17. WOLF P, INOUE Y, RODER-WANNER UU, TSAI JJ. Psychiatric complications of absence therapy and their relation to alteration of sleep. Epilepsia 1984;25(Suppl. 1):S56-9.
18. RING H, TRIMBLE MR, SCHMITZ B. Neuropsychiatric aspects of epilepsy. In: FOGEL BS, SCHIFFER RB, RAO SM, eds. Neuropsychiatry. Baltimore: Williams & Wilkins, 1996, 771-803.
19. KANEMOTO K, TSUJI T, KAWASAKI J. Reexamination of interictal psychoses based on DSMIV psychosis classification and international epilepsy classification. Epilepsia 2001;42:98-103.
20. LEVINSON DF, DEVINSKY O. Psychiatric adverse events during vigabatrin therapy. Neurology 1999;22:1503-11.
21. THOMAS L, TRIMBLE M, SCHMITZ B, RING H. Vigabatrin and behaviour disorders: a retrospective survey. Epilepsy Res 1996;25:21-7.
22. TRIMBLE MR, RUSCH N, BETTS T, CRAWFORD PM. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 2000;9:249-54.
23. MESAD SM, DEVINSKY O. Levetiracetam related aggression. Absract, presented at the APA, 2002.
24. GILLHAM R, BAKER G, THOMPSON P et al. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Res 1996;24:47-55.
25. EDWARDS KR, SACKELLARES JC, VUONG A, HAMMER AE, BARRETT PS. Lamotrigine monotherapy improves depressive symptoms in epilepsy: a double-blind comparison with valproate. Epilepsy Behav 2001;2:28-36.
26. BERAN RG, GIBSON RJ. Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 1998;39:280-2.
27. ETTINGER AB, WEISBROT DM, SARACCO J, DHOON A, KANNER A, DEVINSKY O. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998;39:874-7.
28. KETTER TA, POST RM, THEODORE WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53(Suppl. 2):S53-67.
29. SEIDENBERG M, BECK N, GEISSER M et al. Academic achievement of children with epilepsy. Epilepsia 1986;27:753-9.
30. BOURGEOIS BF, PRENSKY AL, PALKES HS, TALENT BK, BUSCH SG. Intelligence in epilepsy: a prospective study in children. Ann Neurol 1983;14:438-44.
31. BENNETT-LEVY J, STORES G. The nature of cognitive dysfunction in school-children with epilepsy. Acta Neurol Scand 1984;66(Suppl. 99):79-82.
32. CAMFIELD CS, CHAPLIN S, DOYLE AB, SHAPIRO SH, CUMMINGS C, CAMFIELD PR. Side effects of phenobarbital in toddlers; behavioral and cognitive aspects. J Pediatr 1979;95:361-5.
33. FARWELL JR, LEE YJ, HIRTZ DG, SULZBACHER SI, ELLENBERG JH, NELSON KB. Phenobarbital for febrile seizures - effects on intelligence and on seizure recurrence. N Engl J Med 1990;8:364-9.
34. VINING EP, MELLITIS ED, DORSEN MM et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987;80:165-74.
35. STORES G, WILLIAMS PL, STYLES E, ZAIWALLA Z. Psychological effects of sodium valproate and carbamazepine in epilepsy. Arch Dis Child 1992;67:1330-7.
36. FORSYTHE I, BUTLER R, BERG I, MCGUIRE R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991;33:524-34.
37. ALDENKAMP AP, ALPHERTS WC, BLENNOW G et al. Withdrawal of antiepileptic medication in children - effects on cognitive function. The Multicenter Holmfrid Study. Neurology 1993;43:41-50.
38. AMAN MG, WERRY JS, PAXTON JW, TURBOTT SH. Effect of sodium valproate on psychomotor performance in children as a function of dose, fluctuations in concentration, and diagnosis. Epilepsia 1987;28:115-24.
39. AMAN MG, WERRY JS, PAXTON JW, TURBOTT SH, STEWART AW. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia 1990;31:51-60.
40. UVEBRANT P, BAUZIENE R. IntracTable epilepsy in children: the efficacy of lamotrigine treatment, including non-seizure related benefits. Neuropediatrics 1994;25:284-9.
41. WOLF SM, SHINNAR S, KANG H, GIL KB, MOSHE SL. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1995;36:1203-5.
42. KHURANA DS, RIVIELLO J, HELMERS S, HOLMES G, ANDERSON J, MIKATI MA. Efficacy of gabapentin in children with refractory partial seizures. J Pediatr 1996;128:829-33.
43. DULAC O, CHIRON C, LUNA D et al. Vigabatrin in childhood epilepsy. J Child Neurol Supplement 1991;2:S30-7.
44. THOMAS L, TRIMBLE M, SCHIMTZ B, RING H. Vigabatrin and behavior disorders: a retrospective survey. Epilepsy Res 1996;25:21-7.
45. DOOLEY JM, CAMFIELD PR, SMITH E, LANGEVIN P, RONEN G. Topiramate in intractable childhood onset epilepsy - a cautionary note. Can J Neurol Sci 1999;26:271-3.
46. GERBER PE, HAMIWKA L, CONNOLLY MB, FARRELL K. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate. Pediatr Neurol 2000;22: 200-3.
47. TALLIS R, BOON P, PERUCCA E, STEPHEN L. Epilepsy in elderly people: management issues. Epileptic Disord 2002;4(Suppl. 2):S33-9.
48. SMITH DB, MATTSON RH, CRAMER JA, COLLINS JF, NOVELLY RA, CRAFT B. Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone. Epilepsia 1987;28(Suppl. 3):S50-8.
49. MEADOR KJ, LORING DW, HUH K, GALLAGHER BB, KING DW. Comparative cognitive effects of anticonvulsants. Neurology 1990;40(3 Part 1):391-4.
50. PREVEY ML, DELANEY RC, CRAMER JA, CATTANACH L, COLLINS JF, MATTSON RH. Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 1996;53:1008-16.
51. TALLIS R, HALL G, CRAIG I, DEAN A. How common are epileptic seizures in old age? Age Ageing 1991;20:442-8.
52. READ CL, STEPHEN LJ, STOLAREK IH, PAUL A, SILLS GJ, BRODIE MJ. Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study. Seizure 1998;7:159-62.
53. MULA M, TRIMBLE MR, THOMPSON P, SANDER JW. Topiramate and word-finding difficulties in patients with epilepsy. Neurology 2003;8:60:1104-7.
54. ROSENFELD WE, SACHDEO RC, FAUGHT RE, PRIVITERA M. Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia 1997;38(Suppl. 1):S34-6.
55. TATUM WO IV, FRENCH JA, FAUGHT E et al. Postmarketing experience with topiramate and cognition. Post-marketing antiepileptic drug survey. Epilepsia 2001;42:1134-40.
56. ALDENKAMP AP, BAKER G, MULDER OG et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-78.
57. LEACH JP, GIRVAN J, PAUL A, BRODIE MJ. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997;62:372-6.
58. MARTIN R, MEADOR K, TURRENTINE L et al. Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia 2001;42:764-71.
59. ALDENKAMP AP, BAKER G. A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav 2001;2:85-91.
60. FRENCH J, EDRICH P, CRAMER JA. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 2001;47:77-90.
61. NEYENS LG, ALPHERTS WC, ALDENKAMP AP. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995;19:411-9.
62. PEREIRA J, MARSON AG, HUTTON JL. Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2002;3:CD001908.
63. KALVIAINEN R. Long-term safety of tiagabine. Epilepsia 2001;42(Suppl. 3):46-8.
64. CURRAN HV, JAVA R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993;44:529-33.